Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 255 of 5804
-
Massive trial tests antibiotic jab to stop blinding infection after cataract surgery
Prevention Not yet recruitingIntracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis
Phase: PHASE2, PHASE3 • Sponsor: Jason Ahee, M.D. • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New combo therapy may help more liver cancer patients qualify for transplant
Disease control Recruiting nowA single institution, single arm, two-cohort feasibility trial to evaluate the combination of locoregional Y\^90 therapy with systemic atezolizumab and bevacizumab, in participants presenting with hepatocellular carcinoma (HCC) 1) within Milan Criteria (MC) with AFP ≥ 400 ng/ml a…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study aims to protect pregnant women with HIV from deadly TB
Disease control Not yet recruitingBecause pregnant women have been excluded from clinical research, including tuberculosis (TB) research, little is known about diagnosing, treating and preventing TB in pregnant women. We plan to perform a two-stage randomized trial that will identify best practices for screening …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New program aims to slash repeat hospital visits for heart and kidney patients
Disease control Not yet recruitingHealth education and self-management support are key facilitators of health behaviours. Moxie is a mixed media, self-management, education and support program for Albertans living with cardiovascular-related chronic conditions. Moxie is built upon our previous work within the ACC…
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug aims to stop transplant complications in blood cancer patients
Disease control Not yet recruitingThis phase II trial studies how well adding axatilimab to standard of care (SOC) therapy works in preventing graft versus host disease (GVHD) following allogeneic hematopoietic stem cell transplantation (HCT) in patients with hematologic cancer. Allogeneic HCT is a procedure in w…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Virus cocktail takes on tough liver tumors
Disease control Not yet recruitingThis prospective study aims to investigate the efficacy and safety of peritumoral injection of the oncolytic virus H101 in combination with stereotactic body radiotherapy (SBRT), PD-1 monoclonal antibody, chemotherapy, and targeted therapy for the treatment of patients with unres…
Phase: PHASE2 • Sponsor: Jun Huang • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Bladder cancer showdown: can radiation and chemotherapy match surgery?
Disease control Not yet recruitingYour text is mostly clear and well-structured. Here's a slightly polished version for improved clarity and flow: This is a randomized, non-inferiority study comparing radiochemotherapy to radical cystectomy in patients with muscle-invasive bladder cancer. The primary outcome is …
Phase: NA • Sponsor: Brazilian Clinical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New procedure could help stroke patients whose symptoms worsen
Disease control Not yet recruitingThis multicenter, prospective, open-label randomized controlled trial with blinded assessment was designed to assess the efficacy and safety of endovascular treatment for progressive stroke due to vertebrobasilar artery occlusion.
Phase: NA • Sponsor: Feng Gao • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug cocktail takes aim at tough lung cancer
Disease control Not yet recruitingThis is a Phase Ib/II, open-label clinical study designed to evaluate the safety, tolerability, preliminary anti-tumor activity, recommended Phase 2 dose (RP2D), pharmacokinetic (PK) characteristics, and immunogenicity of DXC006 in combination with an immune checkpoint inhibitor …
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control Not yet recruitingThis study was designed as a prospective, multicenter, open-label, randomized controlled trial. Eligible participants were patients aged 15-60 years with high-risk or relapsed/refractory acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or myelodysplastic neoplasm…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Sputum DNA test aims to outsmart Drug-Resistant TB
Diagnosis Not yet recruitingResistance to anti-tuberculosis drugs is a continually growing problem. Multidrug-resistant tuberculosis (MDRTB) is resistance to at least rifampicin and isoniazid, and extensively drug-resistant TB is additional resistance to a fluoroquinolone and a second injectable line drug. …
Phase: NA • Sponsor: University of Cape Town • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New quadruple therapy targets liver cancer and diabetes together
Disease control Not yet recruitingThe purpose of this study is to evaluate the comprehensive therapeutic efficacy and safety profile of the epalrestat combined with hepatic artery infusion chemotherapy (HAIC), donafenib and tislelizumab quadruple regimen in patients with unresectable hepatocellular carcinoma (HCC…
Phase: PHASE2 • Sponsor: Haibo Shao • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
AI could revolutionize heart disease screening in poor regions
Diagnosis Not yet recruitingThe main goal of this project is to see if RADAR (Rapid AI-assisted Detection and Analysis of Rheumatic heart disease), which is a machine and deep-learning AI model, can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test wheth…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Magic mushroom compound tested for depression in new brain scan study
Symptom relief Not yet recruitingDepression is the leading cause of disability worldwide, affecting an estimated 300 million people. Despite available treatments, response rates remain modest, and treatment resistance is common. Novel treatments are needed that act rapidly, produce lasting effects and work diffe…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New drug INV-8989 targets Hard-to-Treat cancers with KRAS G12D mutation
Disease control Recruiting nowThis is a Phase 1 and Phase 2 study to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of INV-8989 in patients with advanced solid tumors harboring KRAS G12D mutations.
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common vitamin a drug tame a deadly immune storm?
Disease control Not yet recruitingThis study is designed to evaluate the safety and preliminary efficacy of all-trans retinoic acid (ATRA) as an initial treatment for patients with active hemophagocytic lymphohistiocytosis (HLH). HLH is a severe hyperinflammatory syndrome caused by excessive activation of immune …
Phase: PHASE2, PHASE3 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Experimental gene therapy targets rare metabolic disease in toddlers
Disease control Recruiting nowPropionic acidemia is a genetic metabolic disorder characterized by metabolic acidosis, ketosis, vomiting, lethargy, cognitive impairment, and risk of death. It results from loss of function of the mitochondrial enzyme propionyl-CoA carboxylase and can be due to disease-causing v…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Pig liver scaffold may speed healing of stubborn diabetic wounds
Disease control Recruiting nowThis study is designed to evaluate whether the Miro3D Wound Matrix, when used in addition to standard of care, improves healing outcomes in patients with chronic diabetic foot ulcers. Diabetic foot ulcers are a common and serious complication of diabetes and may be difficult to …
Phase: NA • Sponsor: Reprise Biomedical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingCholestatic liver diseases are characterized by jaundice, pruritus, and elevated levels of alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT). Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) represent the major autoimmune-driven entities wi…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered immune cells take on incurable blood cancer
Disease control Recruiting nowThe treatment options for multiple myeloma have evolved significantly over the years, providing patients with a range of therapies tailored to their specific circumstances. The choice of treatment often hinges on various factors, including the aggressiveness of the disease, indiv…
Phase: PHASE2 • Sponsor: Dr. Zaineb Akram • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC